SCHEMBL7849223

SCHEMBL7849223

CCCCCCCCC(CO)N(C)S(=O)(=O)c1ccc(N(C)C)cc1Cc1cccc([N+](=O)[O-])c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC10A2 Q12908 2/20 0.35
CYP19A1 P11511 3/20 0.35
MAPK1 P28482 1/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 1/20 0.35
USP2 O75604 1/20 0.34
HPGD P15428 1/20 0.34
XBP1 P17861 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
BAZ1A Q9NRL2 1/20 0.34
CDC25C P30307 1/20 0.34
ENPP1 P22413 1/20 0.34
TBXA2R P21731 1/20 0.34
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7850479 0.86 NPSR1 (0.36) SLC10A2CYP19A1MAPK1ALDH1A1LMNA
SCHEMBL7838193 0.82 ALDH1A1 (0.41) MAPK1ALDH1A1LMNANPSR1CYP1A2
SCHEMBL7846879 0.80 CA1 (0.38) ALDH1A1LMNACYP1A2CYP2C19BAZ1A
SCHEMBL7848483 0.80 LMNA (0.37) SLC10A2CYP19A1MAPK1ALDH1A1LMNA
SCHEMBL7848540 0.79 TBXA2R (0.37) ALDH1A1LMNACYP1A2CYP2C19BAZ1A
SCHEMBL7848868 0.79 SMN1; SMN2 (0.33) SLC10A2MAPK1ALDH1A1LMNANPSR1
SCHEMBL7846313 0.78 ALDH1A1 (0.39) MAPK1ALDH1A1LMNANPSR1CYP1A2
SCHEMBL7837753 0.78 CYP19A1 (0.31) SLC10A2CYP19A1MAPK1ALDH1A1LMNA
SCHEMBL7838190 0.77 LMNA (0.41) SLC10A2MAPK1ALDH1A1LMNANPSR1
SCHEMBL7846307 0.77 PKM (0.39) MAPK1ALDH1A1LMNACYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1155007-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. Searle LLC (US) 2001-11-21 EP disclosed
WO-2000047568-A2 1,2-BENZOTHIAZEPINES FOR THE TREATMENT OF HYPERLIPIDEMIC DISEASES G.D. SEARLE LLC (US) 2000-08-17 WO disclosed